Plant-Based Vaccines Market Outlook From 2026 To 2030: Key Growth Factors And Future Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Plant-Based Vaccines Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?#_x000D_
The plant-based vaccines market has experienced rapid expansion in recent years. This market is projected to expand from $1.81 billion in 2025 to $1.99 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.2%. Historically, this growth can be attributed to several factors, including limited cold chain infrastructure in developing regions, high cost of conventional vaccine production, increasing prevalence of zoonotic diseases, early academic research in plant molecular farming, and government support for alternative biologics._x000D_
_x000D_
The plant-based vaccines market is projected to experience substantial growth in the upcoming years. It is forecast to expand to $3.06 billion in 2030, achieving a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period is primarily driven by an increasing need for scalable vaccine platforms, the development of pandemic preparedness programs, heightened investment in plant biotechnology startups, the demand for affordable veterinary vaccines, and improvements in regulatory pathways for innovative vaccine platforms. Noteworthy trends during this period include the wider application of recombinant antigen expression in plants, the growing adoption of plant-based systems for veterinary vaccines, an intensified focus on developing oral and edible vaccines, increased public and private sector funding for alternative vaccine solutions, and breakthroughs in downstream processing and purification technologies._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Plant-Based Vaccines Market Growth Catalysts And Demand Drivers#_x000D_
The widespread occurrence of infectious diseases is anticipated to drive expansion in the plant-based vaccines market in the future. These diseases are conditions triggered by disease-causing microorganisms like bacteria, viruses, or parasites, capable of transmission through direct or indirect means, presenting substantial global health threats. Factors contributing to the rise in infectious disease incidents include enhanced global movement, dense urban populations, and compromised immune systems within specific groups. Plant-based vaccines provide novel platforms that are quickly scalable and adaptable for tackling these escalating health concerns. An example illustrates this: in March 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based federal agency, indicated an increase in tuberculosis (TB) cases from 8,320 in 2022 to 9,615 in 2023, marking an increment of 1,295 cases. Consequently, the widespread presence of infectious diseases is a key factor boosting the development of the plant-based vaccines market._x000D_
_x000D_
#Plant-Based Vaccines Market Segment Analysis Spotlighting Growth Areas#_x000D_
The plant-based vaccines market covered in this report is segmented – _x000D_
_x000D_
1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types_x000D_
2) By Source: Tobacco Plant, Maize, Potato, Other Sources_x000D_
3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications_x000D_
_x000D_
Subsegments:_x000D_
1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines _x000D_
2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines _x000D_
3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines _x000D_
4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines _x000D_
_x000D_
#Plant-Based Vaccines Market Trends Shaping Long-Term Demand#_x000D_
Major companies in the plant-based vaccines market are entering into strategic manufacturing collaborations to enhance clinical-stage production capabilities and accelerate the advancement of next-generation VLP-based vaccines. These strategic manufacturing partnerships aim to improve downstream processing efficiency, ensure GMP-compliant manufacturing, and support a smooth transition from early-stage research to clinical development. For instance, in December 2024, Aramis Biotechnologies Inc., a Canada-based company specializing in plant-based biomanufacturing of innovative vaccines, partnered with Biodextris Inc., a Canada-based CDMO focused on cGMP complex biologic products, to support Phase 1 and Phase 2 clinical trials. Under this collaboration, the partner will perform purification, formulation, and fill-finish activities for plant-expressed VLP vaccine candidates, enabling faster scale-up, improved production quality, and strengthened readiness for advanced clinical evaluation._x000D_
_x000D_
#Plant-Based Vaccines Market Leading Companies: Who Holds The Strongest Market Presence?#_x000D_
Major companies operating in the plant-based vaccines market are British American Tobacco PLC, Medicago Inc., Creative Biolabs Inc., Fraunhofer USA Inc., Biodextris Inc., Avesthagen Limited, Calyxt Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG, Zyus Life Sciences Inc., Agenus Inc. _x000D_
_x000D_
#View The Full Plant-Based Vaccines Market Report:#_x000D_
_x000D_
#Plant-Based Vaccines Market Regional Split: Which Areas Are Fueling Growth?#_x000D_
North America was the largest region in the plant-based vaccines market in 2025. The regions covered in the plant-based vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
